Breaking
FDA issues warning about some compounded versions of semaglutide for diabetes, weight loss
by admin
0
Like Me

  Likes
22
Views

  Views
0

Shares

FDA issues warning about some compounded versions of semaglutide for diabetes, weight loss

Semaglutide is FDA-approved as Ozempic and Rybelsus to treat type 2 diabetes and as Wegovy to treat overweight and obesity. Ozempic and Wegovy have been on the FDA’s Drug Shortages list since last year.

Source

TOPICS

About admin

Related Posts

French train lines hit by ‘malicious acts’ disrupting traffic ahead of Olympics
French train lines hit by ‘malicious acts’ disrupting traffic ahead of Olympics
17 hours ago
3
Views
0
Like Me

French train lines hit by ‘malicious acts’ disrupting traffic ahead of Olympics

Southwest Airlines is getting rid of open seating, ending a 50-year tradition
Southwest Airlines is getting rid of open seating, ending a 50-year tradition
2 days ago
2
Views
0
Like Me

Southwest Airlines is getting rid of open seating, ending a 50-year tradition

Man accused in deadly shooting outside Hindu temple to face judge
Man accused in deadly shooting outside Hindu temple to face judge
2 days ago
4
Views
0
Like Me

Man accused in deadly shooting outside Hindu temple to face judge

Leave a Reply

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

The reCAPTCHA verification period has expired. Please reload the page.

Facebook
Twitter
Instagram
YouTube

https://bostonlive.net  © 2024

Created By ThemePacific. Powered By WordPress

WP Radio
WP Radio
OFFLINE LIVE